Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus

Gregg T. Lueder, Janet Silverstein, Steven J. Lichtenstein, Edward G. Buckley, George S. Ellis, Jane D. Kivlin, James B. Ruben, Gary T. Denslow, Inger Hansen, Kyle A. Arnoldi, Thomas K. Koch, Michael R. Redmond, Michael X. Repka, S. Niccole Alexander, Surendra Kumar Varma, Stuart J. Brink, Kenneth C. Copeland, Francine R. Kaufman, Paul B. Kaplowitz, Robert P. SchwartzLaura Laskosz

Research output: Contribution to journalShort survey

36 Scopus citations


Diabetic retinopathy (DR) is the leading cause of blindness in young adults in the United States. Early identification and treatment of DR can decrease the risk of vision loss in affected patients. This clinical report reviews the risk factors for the development of DR and screening guidance for pediatric patients with type 1 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)270-273
Number of pages4
Issue number1
StatePublished - Dec 1 2005



  • Diabetic retinopathy
  • Ophthalmic screening
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Lueder, G. T., Silverstein, J., Lichtenstein, S. J., Buckley, E. G., Ellis, G. S., Kivlin, J. D., Ruben, J. B., Denslow, G. T., Hansen, I., Arnoldi, K. A., Koch, T. K., Redmond, M. R., Repka, M. X., Alexander, S. N., Varma, S. K., Brink, S. J., Copeland, K. C., Kaufman, F. R., Kaplowitz, P. B., ... Laskosz, L. (2005). Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics, 116(1), 270-273.